A Anton Torres (Antonio Antón-Torres)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Mesenchymal Stem Cells

Metastatic Breast Cancer

Top Venues

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Noelia Martínez Jáñez, Meritxell Bellet-Ezquerra, Luis Manso Sanchez, Fernando Henao, A Anton Torres, Serafin Morales Murillo, P Tolosa Ortega, V L Obadia Gil, T Sampedro, R Andrés Conejero, L Calvo-Martinez, Elena Galve-Calvo, Rafael López, Francisco Ayala, Miguel Martín, B A Hernando Fernandez de Araguiz, L Boronat Ruiz, T Martos Cardenas, J I Chacon, Fernando Moreno Antón
First-line therapy with palbociclib in patients with advanced HR + /HER2 - breast cancer: The real-life study PALBOSPAIN. Breast cancer research and treatment (2024)
Noelia Martínez Jáñez, Meritxell Bellet-Ezquerra, Luis Manso Sanchez, Fernando Henao, A Anton Torres, Serafin Morales Murillo, P Tolosa Ortega, V L Obadia Gil, T Sampedro, R Andrés Conejero, L Calvo-Martinez, Elena Galve-Calvo, Rafael López, Francisco Ayala, Miguel Martín, B A Hernando Fernandez de Araguiz, L Boronat Ruiz, T Martos Cardenas, J I Chacon, Fernando Moreno Antón
First-line therapy with palbociclib in patients with advanced HR + /HER2 - breast cancer: The real-life study PALBOSPAIN. Breast cancer research and treatment 206 (2) (2024)
Noelia Martínez Jáñez, Meritxell Bellet-Ezquerra, Luis Manso Sanchez, Fernando Henao, A Anton Torres, Serafin Morales Murillo, P Tolosa Ortega, V L Obadia Gil, T Sampedro, R Andrés Conejero, L Calvo-Martinez, Elena Galve-Calvo, Rafael López, Francisco Ayala, Miguel Martín, B A Hernando Fernandez de Araguiz, L Boronat Ruiz, T Martos Cardenas, J I Chacon, Fernando Moreno Antón
First-line therapy with palbociclib in patients with advanced HR + /HER2 - breast cancer: The real-life study PALBOSPAIN. Breast cancer research and treatment 206 (2) (2024)
Noelia Martínez Jáñez, Meritxell Bellet-Ezquerra, Luis Manso Sanchez, Fernando Henao, A Anton Torres, Serafin Morales Murillo, P Tolosa Ortega, V L Obadia Gil, T Sampedro, R Andrés Conejero, L Calvo-Martinez, Elena Galve-Calvo, Rafael López, Francisco Ayala, Miguel Martín, B A Hernando Fernandez de Araguiz, L Boronat Ruiz, T Martos Cardenas, J I Chacon, Fernando Moreno Antón
First-line therapy with palbociclib in patients with advanced HR + /HER2 - breast cancer: The real-life study PALBOSPAIN. Breast cancer research and treatment 206 (2) (2024)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment 204 (2) (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment 204 (2) (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment 204 (2) (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment 204 (2) (2023)